Breaking News Instant updates and real-time market news.

EPZM

Epizyme

$9.65 /

-0.13 (-1.33%)

12:05
03/02/21
03/02
12:05
03/02/21
12:05

Epizyme to initiate basket trials in additional heme, solid tumors in 2H21

Epizyme will initiate two signal finding basket studies to evaluate tazemetostat safety and efficacy across multiple new types of heme and solid tumors. With this approach, the Company will study multiple combinations with standard of care therapies and novel mechanisms of action to expand the potential of TAZVERIK to patients and the physicians who treat them. Epizyme announced on today's call that it plans to initiate both basket studies in the second half of 2021.

  • 02

    Mar

EPZM Epizyme
$9.65 /

-0.13 (-1.33%)

02/25/21 Morgan Stanley
Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley
02/25/21 Morgan Stanley
Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley
02/24/21 Citi
Epizyme price target lowered to $27 from $35 at Citi
12/21/20 Jefferies
Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view

TODAY'S FREE FLY STORIES

Recommendations
Kirkland Lake Gold price target raised to C$52 from C$51 at National Bank » 10:47
04/23/21
04/23
10:47
04/23/21
10:47
KL

Kirkland Lake Gold

$38.32 /

-0.255 (-0.66%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KL Kirkland Lake Gold
$38.32 /

-0.255 (-0.66%)

KL Kirkland Lake Gold
$38.32 /

-0.255 (-0.66%)

04/16/21 TD Securities
Kirkland Lake Gold upgraded to Action List Buy from Buy at TD Securities
04/06/21 Scotiabank
Kirkland Lake Gold price target lowered to C$61 from C$68 at Scotiabank
04/01/21 TD Securities
Kirkland Lake Gold price target raised to C$77 from C$75 at TD Securities
03/17/21 National Bank
Kirkland Lake downgraded to Sector Perform from Outperform at National Bank
KL Kirkland Lake Gold
$38.32 /

-0.255 (-0.66%)

KL Kirkland Lake Gold
$38.32 /

-0.255 (-0.66%)

Hot Stocks
Liberty TripAdvisor Holdings trading resumes  10:46
04/23/21
04/23
10:46
04/23/21
10:46
 
Recommendations
Kinross Gold price target raised to C$14 from C$13.75 at National Bank » 10:46
04/23/21
04/23
10:46
04/23/21
10:46
KGC

Kinross Gold

$7.44 /

-0.1 (-1.33%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KGC Kinross Gold
$7.44 /

-0.1 (-1.33%)

KGC Kinross Gold
$7.44 /

-0.1 (-1.33%)

02/11/21 Barclays
Kinross Gold price target raised to $10 from $9 at Barclays
02/10/21 JPMorgan
Kinross initiated with Overweight, added to Focus List at JPMorgan
02/08/21 Stifel
Kinross Gold price target lowered to C$14.50 from C$14.75 at Stifel
01/11/21 National Bank
Kinross Gold price target lowered to C$17.25 from C$18 at National Bank
KGC Kinross Gold
$7.44 /

-0.1 (-1.33%)

KGC Kinross Gold
$7.44 /

-0.1 (-1.33%)

Recommendations
Agnico Eagle price target lowered to C$97 from C$98 at National Bank » 10:45
04/23/21
04/23
10:45
04/23/21
10:45
AEM

Agnico Eagle

$65.86 /

-0.27 (-0.41%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEM Agnico Eagle
$65.86 /

-0.27 (-0.41%)

AEM Agnico Eagle
$65.86 /

-0.27 (-0.41%)

02/23/21 Canaccord
Agnico Eagle price target lowered to C$110 from C$115 at Canaccord
02/23/21 Canaccord
Agnico Eagle selloff overdone, says Canaccord
02/10/21 JPMorgan
Agnico Eagle initiated with a Neutral at JPMorgan
02/02/21 National Bank
Agnico Eagle price target lowered to C$109 from C$112 at National Bank
AEM Agnico Eagle
$65.86 /

-0.27 (-0.41%)

AEM Agnico Eagle
$65.86 /

-0.27 (-0.41%)

Syndicate
Agiliti indicated to open at $15-$16, IPO priced at $14 » 10:45
04/23/21
04/23
10:45
04/23/21
10:45
AGTI

Agiliti

$10.51 /

+ (+0.00%)

Agiliti (AGTI) priced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGTI Agiliti
$10.51 /

+ (+0.00%)

  • 23
    Apr
Options
Futu Holdings call volume above normal and directionally bullish » 10:45
04/23/21
04/23
10:45
04/23/21
10:45
FUTU

Futu Holdings

$139.99 /

+3.99 (+2.93%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

03/17/21 Citi
Futu Holdings price target lowered to $230.30 from $246.50 at Citi
02/26/21 Citi
Futu Holdings price target raised to $246.50 from $119.70 at Citi
02/22/21 86 Research
Futu Holdings downgraded to Hold from Buy at 86 Research
02/16/21 Morgan Stanley
Futu Holdings initiated with an Overweight at Morgan Stanley
  • 21
    Apr
  • 19
    Aug
FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

Hot Stocks
Liberty TripAdvisor Holdings trading halted, volatility trading pause  10:41
04/23/21
04/23
10:41
04/23/21
10:41
 
Syndicate
Treace Medical indicated to open at $22, IPO priced at $17 » 10:36
04/23/21
04/23
10:36
04/23/21
10:36
TMCI

Treace Medical

/

+

Treace Medical Concepts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 23
    Apr
Hot Stocks
AnaptysBio granted conditional marketing authorization for JEMPERLI » 10:36
04/23/21
04/23
10:36
04/23/21
10:36
ANAB

AnaptysBio

$23.51 /

+0.63 (+2.75%)

, GSK

GlaxoSmithKline

$37.58 /

-0.1 (-0.27%)

AnaptysBio (ANAB)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 Truist
AnaptysBio upgraded to Buy from Hold at Truist
03/16/21 Truist
AnaptysBio upgraded to Buy from Hold at Truist
03/09/21 Wedbush
AnaptysBio downgraded to Neutral at Wedbush
GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

04/20/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
04/20/21 UBS
GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
04/20/21 Citi
GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
03/23/21
Fly Intel: Top five analyst downgrades
ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

Options
Rite Aid put volume heavy and directionally bearish » 10:35
04/23/21
04/23
10:35
04/23/21
10:35
RAD

Rite Aid

$18.33 /

+0.14 (+0.77%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

03/25/21 Deutsche Bank
Rite Aid price target raised to $27 from $17 at Deutsche Bank
03/25/21 Deutsche Bank
Rite Aid named short-term buy idea at Deutsche Bank
12/18/20 Deutsche Bank
Rite Aid price target raised to $17 from $9 at Deutsche Bank
11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

General news
Oil Action: WTI crude » 10:35
04/23/21
04/23
10:35
04/23/21
10:35
$ECON

Economic Data

/

+

Oil Action: WTI crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    Inter Pipeline price target raised to C$18 from C$17.50 at Scotiabank » 10:34
    04/23/21
    04/23
    10:34
    04/23/21
    10:34
    IPPLF

    Inter Pipeline

    $14.50 /

    +0.2918 (+2.05%)

    Scotiabank analyst Robert…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    IPPLF Inter Pipeline
    $14.50 /

    +0.2918 (+2.05%)

    IPPLF Inter Pipeline
    $14.50 /

    +0.2918 (+2.05%)

    07:39 Today Stifel
    Inter Pipeline downgraded to Hold at Stifel on strategic review uncertainty
    04/22/21 Stifel
    Inter Pipeline downgraded to Hold from Buy at Stifel
    04/06/21 Stifel
    Inter Pipeline price target raised to C$20.50 from C$20 at Stifel
    02/24/21 National Bank
    Inter Pipeline price target raised to C$18 from C$15 at National Bank
    Recommendations
    CGI Inc. price target raised to C$112 from C$106 at Scotiabank » 10:34
    04/23/21
    04/23
    10:34
    04/23/21
    10:34
    GIB

    CGI Inc.

    $85.50 /

    -0.02 (-0.02%)

    Scotiabank analyst Paul…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GIB CGI Inc.
    $85.50 /

    -0.02 (-0.02%)

    GIB CGI Inc.
    $85.50 /

    -0.02 (-0.02%)

    04/12/21 Societe Generale
    CGI Inc. upgraded to Hold from Sell at Societe Generale
    03/23/21 Desjardins
    CGI Inc. resumed with a Buy at Desjardins
    03/04/21 Edward Jones
    CGI Inc. upgraded to Buy from Hold at Edward Jones
    02/01/21 Barclays
    CGI Inc. price target raised to $89 from $80 at Barclays
    GIB CGI Inc.
    $85.50 /

    -0.02 (-0.02%)

    Syndicate
    Rain Therapeutics indicated to open at $27, IPO priced at $17 » 10:33
    04/23/21
    04/23
    10:33
    04/23/21
    10:33
    RAIN

    Rain Therapeutics

    /

    +

    Rain Therapeutics (RAIN)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    • 23
      Apr
    Syndicate
    Latham Group indicated to open at $22, IPO priced at $19 » 10:32
    04/23/21
    04/23
    10:32
    04/23/21
    10:32
    SWIM

    Latham Group

    /

    +

    Latham Group (SWIM)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    • 23
      Apr
    SWIM Latham Group
    /

    +

    Options
    Bristol Myers Squibb call volume above normal and directionally bullish » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25
    BMY

    Bristol-Myers

    $66.89 /

    +0.57 (+0.86%)

    Bullish option flow…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/21/21 Citi
    Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
    04/21/21 Citi
    Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
    04/13/21 Truist
    Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
    04/13/21 Truist
    Bristol-Myers upgraded to Buy from Hold at Truist
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    Conference/Events
    Cowen pharmaceuticals analysts to hold analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25
    BMY

    Bristol-Myers

    $66.89 /

    +0.57 (+0.86%)

    Pharmaceuticals Analysts…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/21/21 Citi
    Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
    04/21/21 Citi
    Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
    04/13/21 Truist
    Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
    04/13/21 Truist
    Bristol-Myers upgraded to Buy from Hold at Truist
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    Conference/Events
    Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25

    Large Cap & Biopharma…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Conference/Events
    UBS technology analyst to hold an analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25

    Technology Analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Conference/Events
    Truist digital advertising analysts to hold analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25

    Digital Ad Analysts,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Hot Stocks
    Allegiance Bancshares approves stock repurchase authorization up to 1M shares » 10:24
    04/23/21
    04/23
    10:24
    04/23/21
    10:24
    ABTX

    Allegiance Bancshares

    $39.02 /

    + (+0.00%)

    On April 22, 2021, the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    10/02/20 Janney Montgomery Scott
    Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    Recommendations
    WeCommerce price target lowered to C$23 from C$26 at TD Securities » 10:23
    04/23/21
    04/23
    10:23
    04/23/21
    10:23
    WECMF

    WeCommerce

    $14.79 /

    +0.4312 (+3.00%)

    TD Securities analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Hot Stocks
    Allegiance Bancshares appoints Raimundo Riojas to board of directors » 10:23
    04/23/21
    04/23
    10:23
    04/23/21
    10:23
    ABTX

    Allegiance Bancshares

    $39.02 /

    + (+0.00%)

    Allegiance Bancshares…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    10/02/20 Janney Montgomery Scott
    Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    Recommendations
    Intact Financial price target raised to C$185 from C$175 at TD Securities » 10:22
    04/23/21
    04/23
    10:22
    04/23/21
    10:22
    IFCZF

    Intact Financial

    $130.32 /

    -0.03 (-0.02%)

    TD Securities analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    IFCZF Intact Financial
    $130.32 /

    -0.03 (-0.02%)

    02/12/21 Desjardins
    Intact Financial price target raised to C$175 from C$170 at Desjardins
    02/10/21 National Bank
    Intact Financial price target raised to C$200 from C$192 at National Bank
    02/10/21 TD Securities
    Intact Financial price target raised to C$175 from C$170 at TD Securities
    12/08/20 Scotiabank
    Intact Financial price target raised to C$175 from C$166 at Scotiabank
    Hot Stocks
    GlaxoSmithKline reports European Commission approves Jemperli » 10:22
    04/23/21
    04/23
    10:22
    04/23/21
    10:22
    GSK

    GlaxoSmithKline

    $37.65 /

    -0.03 (-0.08%)

    GlaxoSmithKline announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    04/20/21 Morgan Stanley
    GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
    04/20/21 UBS
    GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
    04/20/21 Citi
    GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
    03/23/21
    Fly Intel: Top five analyst downgrades
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.